Abstract
Background: Financial incentives may improve the initiation and engagement of behaviour change that reduce the negative outcomes associated with non-communicable diseases. There is still a paucity in guidelines or recommendations that help define key aspects of incentive-oriented interventions, including the type of incentive (e.g. cash rewards, vouchers), the frequency and magnitude of the incentive, and its mode of delivery. We aimed to systematically review the literature on financial incentives that promote healthy lifestyle behaviours or improve health profiles, and focused on the methodological approach to define the incentive intervention and its delivery. The protocol was registered at PROSPERO on 26 July 2018 (CRD42018102556). Methods: We sought studies in which a financial incentive was delivered to improve a health-related lifestyle behaviour (e.g., physical activity) or a health profile (e.g., HbA1c in people with diabetes). The search (which took place on March 3rd 2018) was conducted using OVID (MEDLINE and Embase), CINAHL and Scopus. Results: The search yielded 7,575 results and 37 were included for synthesis. Of the total, 83.8% (31/37) of the studies were conducted in the US, and 40.5% (15/37) were randomised controlled trials. Only one study reported the background and rationale followed to develop the incentive and conducted a focus group to understand what sort of incentives would be acceptable for their study population. There was a degree of consistency across the studies in terms of the direction, form, certainty, and recipient of the financial incentives used, but the magnitude and immediacy of the incentives were heterogeneous. Conclusions: The available literature on financial incentives to improve health-related lifestyles rarely reports on the rationale or background that defines the incentive approach, the magnitude of the incentive and other relevant details of the intervention, and the reporting of this information is essential to foster its use as potential effective interventions.
Funder
FONDECYT
Wellcome Trust
Swiss National Science Foundation
DFID/MRC/Wellcome Global Health Trials
Alliance for Health Policy and Systems Research
Biotechnology and Biological Sciences Research Council
Inter-American Institute for Global Change Research
World Diabetes Foundation
Wellcome Trust Clinical Research Career Development Fellowship
National Heart, Lung and Blood Institute
Fogarty International Center
Medical Research Council
Bloomberg Philanthropies
Wellcome Trust International Training Fellowship
National Institute of Mental Health
Bernard Lown Scholars in Cardiovascular Health Program
Grand Challenges Canada
International Development Research Center Canada
UKRI GCRF/Newton Fund
British Embassy and the Newton-Paulet Fund
British Council
National Cancer Institute
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)